Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Spyropoulou-Vlachou, M."" wg kryterium: Wszystkie pola


Tytuł:
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease
Autorzy:
Kastritis, E
Terpos, E
Moulopoulos, L
Spyropoulou-Vlachou, M
Kanellias, N
Eleftherakis-Papaiakovou, E
Gkotzamanidou, M
Migkou, M
Gavriatopoulou, M
Roussou, M
Tasidou, A
Dimopoulos, M AAff1, IDleu2012309_cor12
Pokaż więcej
Źródło:
Leukemia. 27(4):947-953
Czasopismo naukowe
Tytuł:
Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease.
Autorzy:
Kastritis E; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Rousakis P; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Kostopoulos IV; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Gavriatopoulou M; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Theodorakakou F; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Fotiou D; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Dialoupi I; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Migkou M; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Roussou M; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Kanellias N; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Tselegkidi MI; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Eleutherakis-Papaiakovou E; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Papanikolaou A; Department of Hematopathology, Evangelismos' Hospital'.
Gakiopoulou C; 1st Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece.
Psimenou E; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Spyropoulou-Vlachou M; Immunology Unit, 'Alexandra' Hospital, Athens, Greece.
Gatou A; Blood Bank, 'Alexandra' Hospital, Athens, Greece.
Terpos E; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Tsitsilonis O; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Dimopoulos MA; Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Pokaż więcej
Źródło:
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2021 Dec; Vol. 28 (4), pp. 259-266. Date of Electronic Publication: 2021 Sep 01.
Typ publikacji:
Journal Article
MeSH Terms:
Immunoglobulin Light-chain Amyloidosis*/drug therapy
Multiple Myeloma*
Antibodies, Monoclonal/therapeutic use ; Bortezomib/therapeutic use ; Humans ; Neoplasm Recurrence, Local ; Treatment Outcome ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis.
Autorzy:
Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Fotiou D; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Theodorakakou F; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Dialoupi I; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Migkou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Roussou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Karatrasoglou EA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Tselegkidi MI; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Ntalianis A; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Kanellias N; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Eleutherakis-Papaiakovou E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Ntanasis-Stathopoulos I; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Gakiopoulou C; 1st Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece.
Papanikolaou A; Department of Hemopathology, 'Evangelismos' Hospital, Athens, Greece.
Papathoma A; Immunology Unit, 'Alexandra' Hospital, Athens, Greece.
Spyropoulou-Vlachou M; Immunology Unit, 'Alexandra' Hospital, Athens, Greece.
Psimenou E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Stamatelopoulos K; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Gavriatopoulou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Pokaż więcej
Źródło:
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2021 Mar; Vol. 28 (1), pp. 3-11. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji:
Journal Article
MeSH Terms:
Bortezomib/*administration & dosage
Immunoglobulin Light Chains/*blood
Immunoglobulin Light-chain Amyloidosis/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Bortezomib/adverse effects ; Disease-Free Survival ; Female ; Humans ; Immunoglobulin Light-chain Amyloidosis/blood ; Immunoglobulin Light-chain Amyloidosis/physiopathology ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood
Czasopismo naukowe
Tytuł:
Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review.
Autorzy:
Gichuru, Wanjiku (AUTHOR)
Abinya, Nicholas A. O. (AUTHOR)
Odhiambo, Andrew (AUTHOR)
Otieno, Fredrick C. F. (AUTHOR)
Harrison, Simon (AUTHOR)
Ong'ondi, Matilda (AUTHOR)
Pokaż więcej
Źródło:
Advances in Hematology. 2/12/2024, Vol. 2024, p1-6. 6p.
Czasopismo naukowe
Tytuł:
Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure.
Autorzy:
Gil Laborda, Raquel (AUTHOR)
de Frías, Edgard Rodríguez (AUTHOR)
Subhi-Issa, Nabil (AUTHOR)
de Albornoz, Elena Carrillo (AUTHOR)
Meliá, Elena (AUTHOR)
Órdenes, Marcos (AUTHOR)
Verdú, Victoria (AUTHOR)
Vidal, Juan (AUTHOR)
Suárez, Esther (AUTHOR)
Santillán, Isabel (AUTHOR)
Ordóñez, Daniel (AUTHOR)
Pintado-Vera, David (AUTHOR)
González Villafáñez, Victoria (AUTHOR)
Lorenzo, Ángel (AUTHOR)
Fariñas, Manuel (AUTHOR)
Rodríguez-Paíno, Mario (AUTHOR)
Núñez Beltrán, María (AUTHOR)
García Segovia, Áurea (AUTHOR)
del Olmo, Ainhoa (AUTHOR)
Martín Cañadas, Fernando (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 2/9/2024, Vol. 14 Issue 1, p1-10. 10p.
Czasopismo naukowe
Tytuł:
Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis.
Autorzy:
Kastritis E; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Gavriatopoulou M; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Roussou M; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Bagratuni T; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Migkou M; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Fotiou D; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Ziogas DC; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Kanellias N; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Eleutherakis-Papaiakovou E; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Dialoupi I; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Ntanasis-Stathopoulos I; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Spyropoulou-Vlachou M; b Immunology Department 'Alexandra' Hospital , Athens , Greece.
Psimenou E; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Gakiopoulou H; c 1st Department of Pathology , National and Kapodistrian University of Athens , Athens , Greece.
Marinaki S; d Nephrology Unit , ' Laikon' Hospital, National and Kapodistrian University of Athens , Athens , Greece.
Papadopoulou E; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Ntalianis A; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Terpos E; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Dimopoulos MA; a Department of Clinical Therapeutics , National and Kapodistrian University of Athens , Athens , Greece.
Pokaż więcej
Źródło:
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2018 Dec; Vol. 25 (4), pp. 234-241. Date of Electronic Publication: 2019 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Salvage Therapy*
Angiogenesis Inhibitors/*therapeutic use
Immunoglobulin Light-chain Amyloidosis/*drug therapy
Lenalidomide/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Immunoglobulin Light-chain Amyloidosis/pathology ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Evaluation of HLA-G Expression in Multipotent Mesenchymal Stromal Cells Derived from Vitrified Wharton's Jelly Tissue.
Autorzy:
Mallis P; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 115 27 Athens, Greece. .
Boulari D; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 115 27 Athens, Greece. .
Michalopoulos E; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 115 27 Athens, Greece. .
Dinou A; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 115 27 Athens, Greece. .
Spyropoulou-Vlachou M; Immunology Department-Tissue Typing Lab, 'Alexandra' General Hospital of Athens, Lourou Street, 11528 Athens, Greece. .
Stavropoulos-Giokas C; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 115 27 Athens, Greece. .
Pokaż więcej
Źródło:
Bioengineering (Basel, Switzerland) [Bioengineering (Basel)] 2018 Nov 01; Vol. 5 (4). Date of Electronic Publication: 2018 Nov 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Non-Inherited Maternal Antigens Identify Acceptable HLA Mismatches: A New Policy for the Hellenic Cord Blood Bank.
Autorzy:
Panagouli E; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 11527 Athens, Greece. .
Dinou A; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 11527 Athens, Greece. .
Mallis P; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 11527 Athens, Greece. .
Michalopoulos E; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 11527 Athens, Greece. .
Papassavas A; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 11527 Athens, Greece. .
Spyropoulou-Vlachou M; Immunology Division, General Hospital of Athens 'Alexandra', Lourou Street, 11528 Athens, Greece. .
Meletis J; Department of Hematology and Bone Marrow Transplantation, School of Medicine, National and Kapodistrian University of Athens, 17, Agiou Thoma Street, 11527 Athens, Greece. .
Angelopoulou M; Department of Hematology and Bone Marrow Transplantation, School of Medicine, National and Kapodistrian University of Athens, 17, Agiou Thoma Street, 11527 Athens, Greece. .
Konstantopoulos K; Department of Hematology and Bone Marrow Transplantation, School of Medicine, National and Kapodistrian University of Athens, 17, Agiou Thoma Street, 11527 Athens, Greece. .
Vassilakopoulos T; Department of Hematology and Bone Marrow Transplantation, School of Medicine, National and Kapodistrian University of Athens, 17, Agiou Thoma Street, 11527 Athens, Greece. .
Stavropoulos-Giokas C; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 11527 Athens, Greece. .
Pokaż więcej
Źródło:
Bioengineering (Basel, Switzerland) [Bioengineering (Basel)] 2018 Sep 21; Vol. 5 (4). Date of Electronic Publication: 2018 Sep 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
HLA-DQA1*0505 sharing and Killer Immunoglobulin-like Receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.
Autorzy:
Varla-Leftherioti, M.
Keramitsoglou, T.
Parapanissiou, E.
Kurpisz, M.
Kontopoulou-Antonopoulou, V.
Tsekoura, C.
Kamieniczna, M.
Novokowska, B.
Paparistidis, N.
Vrani, V.
Daniilidis, M.
Spyropoulou-Vlachou, M.
Pokaż więcej
Temat:
HLA histocompatibility antigens
IMMUNOGLOBULINS
EMBRYO transfer
POLYMERASE chain reaction
AUTOIMMUNE diseases
Źródło:
Tissue Antigens; Jun2010, Vol. 75 Issue 6, p668-672, 5p, 1 Chart
Czasopismo naukowe
Tytuł:
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial.
Autorzy:
Leypoldt, Lisa B. (AUTHOR)
Gavriatopoulou, Maria (AUTHOR)
Besemer, Britta (AUTHOR)
Salwender, Hans (AUTHOR)
Raab, Marc S. (AUTHOR)
Nogai, Axel (AUTHOR)
Khandanpour, Cyrus (AUTHOR)
Runde, Volker (AUTHOR)
Jauch, Anna (AUTHOR)
Zago, Manola (AUTHOR)
Martus, Peter (AUTHOR)
Goldschmidt, Hartmut (AUTHOR)
Bokemeyer, Carsten (AUTHOR)
Dimopoulos, Meletios A. (AUTHOR)
Weisel, Katja C. (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Sep2023, Vol. 15 Issue 18, p4667. 13p.
Czasopismo naukowe
Tytuł:
Efficient Decellularization of the Full-Thickness Rat-Derived Abdominal Wall to Produce Acellular Biologic Scaffolds for Tissue Reconstruction: Promising Evidence Acquired from In Vitro Results.
Autorzy:
Skepastianos, George (AUTHOR)
Mallis, Panagiotis (AUTHOR)
Kostopoulos, Epameinondas (AUTHOR)
Michalopoulos, Efstathios (AUTHOR)
Skepastianos, Vasileios (AUTHOR)
Palazi, Chrysoula (AUTHOR)
Pannuto, Lucia (AUTHOR)
Tsourouflis, Gerasimos (AUTHOR)
Pokaż więcej
Źródło:
Bioengineering (Basel). Aug2023, Vol. 10 Issue 8, p913. 20p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies